z-logo
open-access-imgOpen Access
Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open-label case series
Author(s) -
Behrooz Ataei,
Mahsa Khodadoostan,
Babk Pouria,
Peyman Adibi
Publication year - 2016
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/2279-042x.185714
Subject(s) - medicine , gastroenterology , hepatitis b virus , serology , alanine transaminase , hepatitis b , viral load , hepatitis , population , antibody , virus , immunology , virology , environmental health
Tenofovir is among the first-line treatments for chronic hepatitis B (CHB) virus infection. We evaluated the efficacy and safety of Tenofovir in treatment of Iranian patients with CHB.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here